Share on StockTwits

Reckitt Benckiser Group Plc (LON:RB)‘s stock had its “sector perform” rating reaffirmed by equities research analysts at RBC Capital in a research note issued to investors on Friday. They currently have a GBX 5,200 ($86.29) price target on the stock. RBC Capital’s price objective indicates a potential downside of 3.08% from the stock’s previous close.

Several other analysts have also recently commented on the stock. Analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Reckitt Benckiser Group Plc in a research note on Friday. They now have a GBX 4,700 ($78.00) price target on the stock. Separately, analysts at Commerzbank AG reiterated a “hold” rating on shares of Reckitt Benckiser Group Plc in a research note on Thursday. They now have a GBX 5,100 ($84.63) price target on the stock. Finally, analysts at Canaccord Genuity reiterated a “sell” rating on shares of Reckitt Benckiser Group Plc in a research note on Wednesday. They now have a GBX 4,500 ($74.68) price target on the stock. Five investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have given a buy rating to the company. Reckitt Benckiser Group Plc presently has a consensus rating of “Hold” and an average target price of GBX 4,962.82 ($82.36).

Reckitt Benckiser Group Plc (LON:RB) opened at 5320.00 on Friday. Reckitt Benckiser Group Plc has a one year low of GBX 4225.00 and a one year high of GBX 5420.00. The stock has a 50-day moving average of GBX 5188.91 and a 200-day moving average of GBX 5028.31. The company’s market cap is £38.468 billion.

Reckitt Benckiser Group Plc is manufacturer and marketer of branded products in household, health and personal care, selling a range through over 60 operating companies into nearly 200 countries.

Receive News & Ratings for Reckitt Benckiser Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.